SynthesisThe clinical respiratory journal2022

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma.

Frank C Albers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.